Reply: Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC/SCAI Consensus Statement.
作者信息
Shah Pinak B, Welt Frederick G P, Mahmud Ehtisham, Phillips Alistair, Anwaruddin Saif
出版信息
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1607-1608. doi: 10.1016/j.jcin.2020.05.035.
Abstract
摘要
相似文献
1
Reply: Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC/SCAI Consensus Statement.回复：2019冠状病毒病（COVID-19）大流行期间结构性心脏病介入治疗转诊患者的分诊考量：美国心脏病学会/心血管造影和介入学会共识声明
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1607-1608. doi: 10.1016/j.jcin.2020.05.035.
2
TAVR During the COVID-19 Pandemic: The ACC/SCAI Consensus Statement.新冠疫情期间的经导管主动脉瓣置换术：美国心脏病学会/心血管造影和介入学会共识声明
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1605-1606. doi: 10.1016/j.jcin.2020.04.053. Epub 2020 May 3.
3
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement.COVID-19 大流行期间结构性心脏病介入治疗转诊患者的分诊考虑：ACC/SCAI 立场声明。
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1484-1488. doi: 10.1016/j.jcin.2020.04.001. Epub 2020 Apr 6.
4
Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement.COVID-19 大流行期间结构性心脏病介入治疗转诊患者的分诊考虑：美国心脏病学会/心血管造影和介入学会立场声明。
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):659-663. doi: 10.1002/ccd.28910. Epub 2020 Jun 8.
5
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic.COVID-19大流行期间严重主动脉瓣狭窄的经导管治疗
Heart. 2020 Aug;106(15):1183-1190. doi: 10.1136/heartjnl-2020-317221. Epub 2020 Jun 10.
6
Performing Structural Heart Disease Interventions During the COVID-19 Pandemic: But What Are the Downsides?在新冠疫情期间实施结构性心脏病干预措施：但有哪些不利之处呢？
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1606-1607. doi: 10.1016/j.jcin.2020.05.007. Epub 2020 May 12.
7
Transcatheter Aortic Valve Replacement in the Coronavirus Disease 2019 (COVID-19) Era.2019年冠状病毒病（COVID-19）时代的经导管主动脉瓣置换术
J Am Heart Assoc. 2020 Jun 2;9(11):e017121. doi: 10.1161/JAHA.120.017121. Epub 2020 May 26.
8
"Minimalist" transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity.新冠疫情期间的“极简式”经导管主动脉瓣植入术：以往是可选项，如今成了必选项。
EuroIntervention. 2020 Aug 7;16(6):e451-e452. doi: 10.4244/EIJV16I6A82.
9
Heartbeat: Heart disease and COVID-19.心跳：心脏病与2019冠状病毒病
Heart. 2020 Aug;106(15):1115-1116. doi: 10.1136/heartjnl-2020-317674.
10
Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 Pandemic.2019年冠状病毒病大流行期间结构性心脏病治疗优先级平衡指南。
Cardiovasc Revasc Med. 2020 Aug;21(8):1030-1033. doi: 10.1016/j.carrev.2020.05.040. Epub 2020 May 30.
引用本文的文献
1
Narrative Review of New Insight into the Influence of the COVID-19 Pandemic on Cardiovascular Care.对 COVID-19 大流行对心血管护理影响的新见解的叙述性综述。
Medicina (Kaunas). 2022 Oct 29;58(11):1554. doi: 10.3390/medicina58111554.
2
Best Practice Recommendations for Optimizing Care in Structural Heart Programs: Planning Efficient and Resource Leveraging Systems (PEARLS).优化结构性心脏病项目护理的最佳实践建议：规划高效且资源利用合理的系统（PEARLS）。
Struct Heart. 2021 Mar-Apr;5(2):168-179. doi: 10.1080/24748706.2021.1877858. Epub 2022 Mar 21.
3
Lessons for Treating Structural Heart Patients during the COVID-19 Pandemic and Beyond.
Struct Heart. 2021 Jun;5(6):591-595. doi: 10.1080/24748706.2021.1981561. Epub 2022 Mar 21.
4
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?意大利在 COVID-19 时代的肺动脉高压悖论：疾病进展的风险就在眼前吗？
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
5
The COVID-19 Pandemic Surge and Impact on Rheumatic Valvular Heart Disease Patient Care.新冠疫情高峰及其对风湿性心脏瓣膜病患者护理的影响。
J Saudi Heart Assoc. 2021 Nov 3;33(4):261-266. doi: 10.37616/2212-5043.1271. eCollection 2021.
6
MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art.用于二尖瓣反流的MitraClip和用于严重主动脉瓣狭窄的经导管主动脉瓣植入术：最新技术。
Postepy Kardiol Interwencyjnej. 2021 Jun;17(2):155-162. doi: 10.5114/aic.2021.107493. Epub 2021 Jul 9.
7
Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?新冠病毒病分阶段治疗：间充质干细胞疗法还有空间吗？
Regen Med. 2021 May;16(5):477-494. doi: 10.2217/rme-2020-0189. Epub 2021 May 14.
8
The Impact of COVID-19 Pandemic on the Hospital Management of TAVI Patients: TAVI Team Thoughts and Recommendation.2019年冠状病毒病大流行对经导管主动脉瓣植入术（TAVI）患者医院管理的影响：TAVI团队的思考与建议
J Saudi Heart Assoc. 2020 May 18;32(5):11-15. doi: 10.37616/2212-5043.1030. eCollection 2020.
9
Consensus Statement on Coronary Intervention during the Coronavirus Disease 2019 (COVID-19) Pandemic: from the Korean Society of Interventional Cardiology (KSIC).韩国介入心脏病学会（KSIC）关于2019冠状病毒病（COVID-19）大流行期间冠状动脉介入治疗的共识声明。
Korean Circ J. 2020 Nov;50(11):974-983. doi: 10.4070/kcj.2020.0283.
10
Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience.成人心血管手术与2019冠状病毒病（COVID-19）大流行：意大利的经验
Interact Cardiovasc Thorac Surg. 2020 Dec 7;31(6):755-762. doi: 10.1093/icvts/ivaa186.
本文引用的文献
1
Performing Structural Heart Disease Interventions During the COVID-19 Pandemic: But What Are the Downsides?在新冠疫情期间实施结构性心脏病干预措施：但有哪些不利之处呢？
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1606-1607. doi: 10.1016/j.jcin.2020.05.007. Epub 2020 May 12.
2
Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes.经导管主动脉瓣置换术中的清醒镇静与全身麻醉：实践与结局的差异。
JACC Cardiovasc Interv. 2020 Jun 8;13(11):1277-1287. doi: 10.1016/j.jcin.2020.03.008.
3
Temporal Trends and Clinical Consequences of Wait Times for Transcatheter Aortic Valve Replacement: A Population-Based Study.经导管主动脉瓣置换术等待时间的时间趋势和临床后果：基于人群的研究。
Circulation. 2018 Jul 31;138(5):483-493. doi: 10.1161/CIRCULATIONAHA.117.033432.
Zotero 插件